Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30203832

A phase 1/2, open-label, dose-escalation study of midostaurin in children with relapsed or refractory acute leukaemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Br J Haematol
Publication date
2019 May
First author
Zwaan CM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Zwaan CM
      type
      Author
    2. name
      Söderhäll S
      type
      Author
    3. name
      Brethon B
      type
      Author
    4. name
      Luciani M
      type
      Author
    5. name
      Rizzari C
      type
      Author
    6. name
      Stam RW
      type
      Author
    7. name
      Besse E
      type
      Author
    8. name
      Dutreix C
      type
      Author
    9. name
      Fagioli F
      type
      Author
    10. name
      Ho PA
      type
      Author
    11. name
      Dufour C
      type
      Author
    12. name
      Pieters R
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Zwaan CM
      type
      Author
    2. name
      Söderhäll S
      type
      Author
    3. name
      Brethon B
      type
      Author
    4. name
      Luciani M
      type
      Author
    5. name
      Rizzari C
      type
      Author
    6. name
      Stam RW
      type
      Author
    7. name
      Besse E
      type
      Author
    8. name
      Dutreix C
      type
      Author
    9. name
      Fagioli F
      type
      Author
    10. name
      Ho PA
      type
      Author
    11. name
      Dufour C
      type
      Author
    12. name
      Pieters R
      type
      Author
    bibliography ids
    1. nci-bib-73fe341e355e402c3503c847
    book metadata
    content sha256
    bad95b0004fb1dcc6fd72eec5f4dd8aa552c5c8300cf67112f7902aadf328e49
    document type
    citation
    dois
    1. 10.1111/bjh.15593
    electronic publication date
    display
    2018 Sep 11
    precision
    day
    year
    2018
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:30203832
    immutable id
    pubmed:30203832@bad95b0004fb1dcc6fd72eec5f4dd8aa552c5c8300cf67112f7902aadf328e49
    journal
    abbreviation
    Br J Haematol
    issn electronic
    1365-2141
    issn print
    0007-1048
    issue
    3
    name
    British journal of haematology
    nlm unique id
    0372544
    pages
    623-627
    volume
    185
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      30203832
      provenance
      batch id
      438b2803888025c6cf56
      provider
      NCBI PubMed ESummary
      record sha256
      84f2bb244f66235fc3e96a4dfa29e74ce126880afc3a980bdc4aca79d743d2a8
      response sha256
      0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
      retrieved at
      2026-09-09T23:47:36.359220+00:00
      publication date
      display
      2019 May
      precision
      month
      year
      2019
      publication types
      1. Clinical Trial, Phase I
      2. Clinical Trial, Phase II
      3. Letter
      4. Multicenter Study
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/30203832/
      title
      A phase 1/2, open-label, dose-escalation study of midostaurin in children with relapsed or refractory acute leukaemia.

      Preserved source evidence · Not medical advice